Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis

ConclusionDespite aggressive immunosuppressive therapies, the short-term mortality of RP-ILD remains high. While immunosuppressive therapies are associated with significant functional improvements in most patients with C-ILD, substantial uncertainty remains about the best treatment strategy in the absence of good quality evidence.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research